source
- Astellas reports promising early results for stem cell eye therapy ASP7317 in age-related diseaseAstellas announced data from an early-stage trial of ASP7317, a stem cell-derived therapy aimed at an age-related eye condition. The study showed encouraging signs of efficacy and safety in most p…
- Health insurers grapple with profit cuts after a costly 2025, outlook for 2026 remains uncertainIn 2025, a wave of health insurers reduced or withdrew their profit forecasts after being hit by rising medical expenses. The cost pressures stemmed from higher drug prices, increased utilization…